Goulbourne, C., & Vaux, D. (2010). HIV protease inhibitors inhibit FACE1/ZMPSTE24: A mechanism for acquired lipodystrophy in patients on highly active antiretroviral therapy? Portland Press.
Cita Chicago (17th ed.)Goulbourne, C., i D. Vaux. HIV Protease Inhibitors Inhibit FACE1/ZMPSTE24: A Mechanism for Acquired Lipodystrophy in Patients on Highly Active Antiretroviral Therapy? Portland Press, 2010.
Cita MLA (9th ed.)Goulbourne, C., i D. Vaux. HIV Protease Inhibitors Inhibit FACE1/ZMPSTE24: A Mechanism for Acquired Lipodystrophy in Patients on Highly Active Antiretroviral Therapy? Portland Press, 2010.
Atenció: Aquestes cites poden no estar 100% correctes.